Company profile for GeneCraft

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

GeneCraft Inc., a South Korea?based preclinical-stage biotech founded on decades of cancer defense research led by Prof. Suk Chul Bae, is pioneering gene therapy targeting Pan-KRAS mutant lung cancer. Its lead program RX001 harnesses a unique innate oncogene defense mechanism to selectively destroy KRAS-mutated cancer cells using its proprietary Ubi-AAV platform. RX001 completed GLP preclinical validation and is preparing for ...
GeneCraft Inc., a South Korea?based preclinical-stage biotech founded on decades of cancer defense research led by Prof. Suk Chul Bae, is pioneering gene therapy targeting Pan-KRAS mutant lung cancer. Its lead program RX001 harnesses a unique innate oncogene defense mechanism to selectively destroy KRAS-mutated cancer cells using its proprietary Ubi-AAV platform. RX001 completed GLP preclinical validation and is preparing for a Phase-1/2 clinical trial in 2025.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
South Korea
Address
Address
1 Chungdae-ro, E-9/480 (Chungbuk National University), Seowon-gu, Cheongju-si,...
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty